跳至主要内容
临床试验/NCT03004963
NCT03004963已完成不适用

Bioimpedance-guided Fluid Management in Chronic Peritoneal Dialysis Patients: A Randomized Controlled Trial

RenJi Hospital1 个研究点 分布在 1 个国家目标入组 213 人开始时间: 2016年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
213
试验地点
1
主要终点
patient mortality

研究概览

简要总结

Peritoneal dialysis (PD) is one of established treatments in the end stage renal disease patients. Volume overload is a predictor of mortality in PD patients. In this Randomized controlled trial, the investigators use the Body Composition Monitor (BCM), a multifrequency bioimpedance device, to measure the level of overhydration in PD patients and explore its value in fluid management in peritoneal dialysis patients as well as their prognosis.

详细描述

Optimal fluid management is one of the primary objectives of dialysis treatment, and there is significant concern that peritoneal dialysis (PD) patients can become progressively fluid-loaded with time on treatment, especially as residual kidney function declines. Body Composition Monitor (BCM) has the potential to enable better management of fluid balance. The investigators undertake a prospective, randomized, open-label, controlled trial to determine whether availability of longitudinal BCM measures help clinicians maintain stable fluid status over 24 months in 300 peritoneal dialysis patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients 18 years or older but no older than 80 years.
  • who had been on chronic peritoneal dialysis for more than 3 months.
  • All of them have signed the informed consent.

排除标准

  • were expected to stop PD treatment in 6 months;
  • were amputees;
  • had a cardiac pacemaker or metallic implants;
  • had peritonitis one month before recruitment;
  • treated together with hemodialysis;
  • were during pregnancy or lactation;
  • were positive with HIV;
  • had serious diseases, including cancer, infection and liver cirrhosis, which were not suitable for the study.

结局指标

主要结局

patient mortality

时间窗: 96 weeks

different rates of all-cause patient mortality and cardiovascular mortality

technique failure

时间窗: 96 weeks

different incidence of technique failure during peritoneal dialysis treatment

The incidence of cardiovascular events

时间窗: 96 weeks

different incidence of cardiovascular diseases

volume status

时间窗: 96 weeks

change in overhydration(OH) value

次要结局

  • residual renal function(96 weeks)
  • peritoneal function(96 weeks)
  • blood pressure(96 weeks)
  • heart function(96 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验